Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

AB InBev's shares rise on 'bruise-free' first quarter



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 5-AB InBev's shares rise on 'bruise-free' first quarter</title></head><body>

Investors welcome better-than-expected results

U.S. Bud Light boycott still weighs on AB InBev

Boycott impact now set to ease

Updates shares in paragraph 1, adds detail on shares in paragraph 4 graphic

By Emma Rumney

LONDON, May 8 (Reuters) -Anheuser-Busch Inbev ABI.BR shares rose more than 5% on Wednesday, in response to a strong first-quarter performance and anticipated relief from the impact of an ongoing U.S. Bud Light boycott.

The world's largest brewer reported a 2.6% rise in revenues, in line with expectations, and better-than-forecast EBITDA and volumes, including in North America, its largest region by revenues, analysts said.

The company, which makes Stella Artois and Corona beer, said it had record volumes in some of its markets, including Brazil and South Africa. EBITDA, meanwhile, grew 5.4%, well ahead of the 1.9% expected by analysts.

Its shares hit their highest level since February, putting them among the biggest gainers on the pan-European STOXX 600 .STOXX.

"We are encouraged by our results to start the year," Chief Executive Michel Doukeris said.

AB Inbev sales in the United States have been hit hard by a consumer boycott of Bud Light that knocked it from the top spot as the best-selling U.S. beer.

Its revenues in the country declined 9.1% in the first quarter, with sales to retailers down 13.7% due to the boycott.

But North America volumes dropped less than expected, and its performance was a big improvement compared with earlier in the boycott, analysts said.

"ABI has got its (likely) hardest quarter of 2024 out of the way with little to no bruises," Barclays analyst Laurence Whyatt said. "Bud Light continues to weigh on results, but this is the last quarter to face a significant impact."

The boycott is related to a conservative backlash against a social media promotion with transgender influencer Dylan Mulvaney.

It began about a year ago, which means that the three months to end-March should be the final quarter of real pain for AB InBev in terms of tough comparatives.

Sales figures from a year ago will include the boycott from here on out, making the comparatives less painful.

All brewers are set for margin expansion as price rises for key supplies from barley to aluminium slow.

Rivals Heineken HEIN.AS and Carlsberg CARLb.CO also produced solid first-quarter results.

AB InBev reported a 5.4% increase in normalised EBITDA to almost $5 billion. The company said it expects full-year EBITDA to grow in line with its medium-term outlook of between 4% and 8%.


AB InBev's share performance over since the Bud Light boycott https://reut.rs/4bv3Md4


Reporting by Emma Rumney; Editing by Jamie Freed, Clarence Fernandez, Kim Coghill, Gerry Doyle and Jane Merriman

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.